Protein profile

PA1505

cyclic pyranopterin monophosphate synthase

Genome: NC_002516.2

Gene: PA1505 moaA2 Structure source: AlphaFold UniProt Q9I3K7
Amino acids 331
Annotations 11
Features 23
PDB binders 3
Druggability 0.606

Overview

Basic information about this protein and its source genome.

Accession
PA1505
Gene
PA1505 moaA2
Status
annotated
Amino acids
331
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
hit
Human identity (%)
38.043
Human E-value
1.23e-41
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.606
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 10 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

10
  • GO:0051539 Binding to a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.
  • GO:0061799 Catalysis of the reaction: (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate = cyclic pyranopterin phosphate + diphosphate.
  • GO:0061798 Catalysis of the reaction: GTP=(8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate.
  • GO:0005525 Binding to GTP, guanosine triphosphate.
  • GO:0046872 Binding to a metal ion.
  • GO:1904047 Binding to S-adenosyl-L-methionine.
  • GO:0006777 The chemical reactions and pathways resulting in the formation of the Mo-molybdopterin cofactor, essential for the catalytic activity of some enzymes. The cofactor consists of a mononuclear molybdenum (Mo) ion coordinated by one or two molybdopterin ligands.
  • GO:0003824 Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
  • GO:0051536 Binding to an iron-sulfur cluster, a combination of iron and sulfur atoms.
  • GO:0019008 OBSOLETE. A protein complex that possesses molybdopterin synthase activity. In E. coli, the complex is a heterotetramer consisting of two MoaD and two MoaE subunits.

Sequence Features

Domain/signature hits from InterPro and related databases.

23 records
Show feature table
Start End DB Term Name
22 124 Pfam PF13353 4Fe-4S single cluster domain
252 321 CDD cd21117 Twitch_MoaA
252 321 InterPro IPR010505 Molybdenum cofactor biosynthesis protein A-like, twitch domain
21 32 ProSitePatterns PS01305 moaA / nifB / pqqE family signature.
21 32 InterPro IPR000385 MoaA/NifB/PqqE, iron-sulphur binding, conserved site
3 331 Gene3D G3DSA:3.20.20.70 Aldolase class I
3 331 InterPro IPR013785 Aldolase-type TIM barrel
186 314 Pfam PF06463 Molybdenum Cofactor Synthesis C
186 314 InterPro IPR010505 Molybdenum cofactor biosynthesis protein A-like, twitch domain
19 184 CDD cd01335 Radical_SAM
6 278 SUPERFAMILY SSF102114 Radical SAM enzymes
9 234 ProSiteProfiles PS51918 Radical SAM core domain profile.
9 234 InterPro IPR007197 Radical SAM
4 331 SFLD SFLDG01072 dehydrogenase like
6 331 NCBIfam TIGR02666 GTP 3',8-cyclase MoaA
6 331 InterPro IPR013483 Molybdenum cofactor biosynthesis protein A
4 331 SFLD SFLDG01383 cyclic pyranopterin phosphate synthase (MoaA-like)
15 219 SMART SM00729 MiaB
15 219 InterPro IPR006638 Elp3/MiaA/NifB-like, radical SAM core domain
5 315 PANTHER PTHR22960 MOLYBDOPTERIN COFACTOR SYNTHESIS PROTEIN A
6 331 Hamap MF_01225_B GTP 3',8-cyclase [moaA].
20 179 Pfam PF04055 Radical SAM superfamily
20 179 InterPro IPR007197 Radical SAM

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA1505
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.606
3 0.266

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

53 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
5AD P69848 251.2 Da LogP -0.95 TPSA 119.3 ✓ Ro5 ✓ Clean C[C@@H]1[C@H]([C@H]([C@@H](O1)n2cnc3c2ncnc3N)O)O
DTU P65388 154.3 Da LogP -0.43 TPSA 40.5 ✓ Ro5 ✓ Clean C([C@H]([C@H](CS)O)O)S
POP P69848 176.0 Da LogP -2.08 TPSA 129.9 ✓ Ro5 ✓ Clean O[P@@](=O)([O-])O[P@@](=O)(O)[O-]

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.